Peptide Atlas · Mineral

Potassium phosphate (injectable)

In a randomized study in critically ill patients with hypophosphatemia, 30 or 45 mmol of intravenous potassium phosphate corrected phosphate by the end of the infusion in 98%, whether given over 2 or 4 hours (moderate) or 3 or 6 hours (severe), with no adverse events.

emerging

provisional
PubChem 24450
1 citation
0 discussions
0 followers
dipotassium hydrogen phosphate (K2HPO4)
monopotassium phosphate (KH2PO4)
potassium phosphate for injection

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 1 citation resolves to their original source. · 0 posts naming it, 0 members counted once each.

- emerging
  Claim: Rapid intravenous potassium phosphate repletion in ICU hypophosphatemia (RCT, n=47) standing
- resolved
Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia.
Charron T, Bernard F, Skrobik Y, Simoneau N, Gagnon N, Leblanc M
pmid 12845429

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.